eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | clear cell renal carcinoma |
| Comorbidity | C0206681|clear cell carcinoma |
| Sentences | 7 |
| PubMedID- 21836820 | Left adrenalectomy was performed, and the final pathological diagnosis was metastatic clear cell carcinoma of the kidney (fig. |
| PubMedID- 22933935 | The primary tumours were clear cell carcinoma of the kidney, squamous cell carcinoma of the lung and breast carcinoma-ductal type. |
| PubMedID- 22429906 | The recent report by o'meara and colleagues [11] that describes a 14-3-3-fam22 fusion in a clear cell carcinoma of the kidney highlights the relevance of these particular cancer-inducing genes. |
| PubMedID- 20667101 | Microscopic examination revealed clear cell carcinoma of the kidney at the stage g1 pt3bn0m0, not infiltrating renal capsule (figure5). |
| PubMedID- 22624114 | Scc must be distinguished from basal cell carcinoma, amelanotic melanoma, squamous cell carcinoma and rarely metastatic clear cell carcinoma of the kidney. |
| PubMedID- 22152020 | Survival analysis was carried out for 169 evaluable patients with complete follow-up data and pathologically proven clear cell carcinoma of the kidney. |
| PubMedID- 21188099 | The results from two recently completed phase 3 trials, demonstrate bevacizumab plus ifn-α is a clinically useful treatment option for patients with good/intermediate risk metastatic clear cell carcinoma of the kidney.5,6 when this regimen is employed, it should be administered as described in the recently published studies.5,6 the choice of therapy for individual patients should be based on perceived risk/benefit ratio as well as the adverse event profile of the therapy. |
Page: 1